Market Tracker

07/22 5:16pm ET

Danaher Corp (NYSE:DHR)

81.24
Delayed Data
As of Jul 22
 -0.05 / -0.06%
Today’s Change
61.58
Today|||52-Week Range
81.80
+15.40%
Year-to-Date
Danaher (DHR) Stock Slips Ahead of Q2 Earnings Report
Jul 22 / TheStreet.com - Paid Partner Content
'Mad Money' Lightning Round: Take Allergan Over Teva
Jul 19 / TheStreet.com - Paid Partner Content
2 Conglomerates' Earnings to Watch on Jul 25: DHR, CR
Jul 22 / Zacks.com - Paid Partner Content
With Danaher Spinoff Transaction Complete, Trifecta Stocks Exit Position With Profit
Jul 18 / TheStreet.com - Paid Partner Content
Danaher (DHR) Q2 Earnings: Stock Likely to Disappoint?
Jul 21 / Zacks.com - Paid Partner Content
What Falling Estimates & Price Mean for Danaher (DHR)
Jul 15 / Zacks.com - Paid Partner Content
Jim Cramer's Top Takeaways: Zoetis, Idexx, Danaher, Fortive
Jul 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close81.29
Today’s open81.40
Day’s range80.66 - 81.46
Volume3,100,062
Average volume (3 months)2,903,976
Market cap$55.9B
Dividend yield0.60%
Data as of 4:00pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+1.06%
Earnings growth (this year)+12.74%
Earnings growth (next 5 years)+5.70%
Revenue growth (last year)+3.26%
P/E ratio26.9
Price/Sales3.20
Price/Book2.36

Competitors

 Today’s
change
Today’s
% change
SYKStryker Corp-5.53-4.51%
BDXBecton Dickinson and...-1.19-0.68%
BSXBoston Scientific Co...0.000.00%
ZBHZimmer Biomet Holdin...-0.81-0.65%
Data as of 4:03pm ET, 07/22/2016

Financials

Next reporting dateJuly 25, 2016
EPS forecast (this quarter)$0.92
Annual revenue (last year)$20.6B
Annual profit (last year)$2.6B
Net profit margin12.64%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Thomas Patrick Joyce
Chief Financial Officer &
Executive Vice President
Daniel L. Comas
Corporate headquarters
Washington, District Of Columbia

Forecasts